Juan Carlos Balandran
Overview
Explore the profile of Juan Carlos Balandran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sosa-Jurado F, Sanchez-Reza L, Mendoza-Torres M, Melendez-Mena D, Garcia Y Garcia V, Guzman-Flores B, et al.
Eur Cytokine Netw
. 2021 Aug;
32(2):23-30.
PMID: 34369380
Chronic hepatitis B (CHB) is classified into five phases based on virus-host interactions: immune tolerance, immune clearance, inactive carrier state, reactive phase and occult hepatitis B infection (OBI). OBI is...
12.
Zapata-Tarres M, Balandran J, Rivera-Luna R, Pelayo R
Curr Oncol Rep
. 2021 Mar;
23(5):56.
PMID: 33755790
Purpose Of Review: Acute leukemias represent a tremendous threat to public health around the globe and the main cause of death due to disease in scholar age children from developing...
13.
Gutierrez-de Anda K, Juarez-Martinez L, Juarez-Avendano G, Pelayo R, Balandran J
Rev Med Inst Mex Seguro Soc
. 2020 Oct;
57(6):379-386.
PMID: 33001614
Exacerbated immune system reactions often trigger allergy pathologies, which include asthma, rhinitis, urticaria, food and drug allergies, insect bites, and may sometimes have fatal outcomes. In Mexico, more than 20%...
14.
Juarez-Avendano G, Luna-Silva N, Chargoy-Vivaldo E, Juarez-Martinez L, Martinez-Rangel M, Zarate-Ortiz N, et al.
Technol Cancer Res Treat
. 2020 Jul;
19:1533033820928436.
PMID: 32608319
Objective: To investigate the cellular and molecular epidemiology of acute leukemias in vulnerable populations of children and adolescents in Oaxaca de Juarez, Mexico. Material And Methods: Descriptive, cross-sectional and retrospective...
15.
Ramirez-Ramirez D, Padilla-Castaneda S, Galan-Enriquez C, Vadillo E, Prieto-Chavez J, Jimenez-Hernandez E, et al.
J Leukoc Biol
. 2019 Feb;
105(5):999-1013.
PMID: 30791148
Due to their increasing rates of morbidity and mortality, childhood malignancies are considered a global health priority, with acute lymphoblastic leukemias (ALLs) showing the highest incidence worldwide. Control of malignant...
16.
Velazquez-Avila M, Balandran J, Ramirez-Ramirez D, Velazquez-Avila M, Sandoval A, Felipe-Lopez A, et al.
Leukemia
. 2018 Dec;
33(6):1337-1348.
PMID: 30573781
Cancer is a major cause of death in children worldwide, with B-lineage cell acute lymphoblastic leukemia (B-ALL) being the most frequent childhood malignancy. Relapse, treatment failure and organ infiltration worsen...
17.
Kourtis N, Lazaris C, Hockemeyer K, Balandran J, Jimenez A, Mullenders J, et al.
Nat Med
. 2018 Jul;
24(8):1157-1166.
PMID: 30038221
Cellular transformation is accompanied by extensive rewiring of many biological processes leading to augmented levels of distinct types of cellular stress, including proteotoxic stress. Cancer cells critically depend on stress-relief...
18.
Espinoza-Sanchez N, Vadillo E, Balandran J, Monroy-Garcia A, Pelayo R, Fuentes-Panana E
Int J Oncol
. 2017 Oct;
51(5):1482-1496.
PMID: 29048610
Breast cancer (BrC) is a major public health problem worldwide. The intra-tumoral heterogeneity and tumor cell plasticity importantly contribute to disease progression and treatment failure. However, the dynamic interactions between...
19.
Balandran J, Vadillo E, Dozal D, Reyes-Lopez A, Sandoval-Cabrera A, Laffont-Ortiz M, et al.
Arch Med Res
. 2017 May;
47(8):629-643.
PMID: 28476191
Background And Aims: Childhood acute leukemias (AL) are characterized by the excessive production of malignant precursor cells at the expense of effective blood cell development. The dominance of leukemic cells...
20.
Balandran J, Purizaca J, Enciso J, Dozal D, Sandoval A, Jimenez-Hernandez E, et al.
Front Immunol
. 2017 Jan;
7:666.
PMID: 28111575
Pediatric oncology, notably childhood acute lymphoblastic leukemia (ALL), is currently one of the health-leading concerns worldwide and a biomedical priority. Decreasing overall leukemia mortality in children requires a comprehensive understanding...